Dr. Parvathaneni specializes in Regulatory Affairs, Clinical Research, Pharmaceuticals and Medical Devices. Dr. Parvathaneni has published more than two dozen research articles extensively on the new drug development for breast cancer, liver diseases and inflammation. He also published his research on development of liposomes, silver nanoparticles and their pharmacological applications in reputed international scientific journals. Dr. Parvathaneni’s research work received international acclaim from more than 20 countries and his research was majorly cited by scientists in USA, Europe, Brazil, Turkey, India and Malaysia. Dr. Parvathaneni most recent academic achievements include Master’s in Project Management in 2017 from Harrisburg University of Science and Technology. He received PhD in pharmaceutical sciences in 2013 from Andhra University where he completed Masters in Pharmaceutical Sciences in 2010. Before these degrees, Dr. Parvathaneni earned his Bachelor’s in Pharmacy from Acharya Nagarjuna University in 2008. He was nominated as full member for Sigma Xi, as an active member for American Association for Cancer Research (AACR) and as Young Scientist by International Academic and Research Excellence Awards. Dr. Parvathaneni has been serving the pharmaceutical and medical device industry from 2014 as a regulatory affairs professional. Dr. Parvathaneni did enormous contributions to the research field by serving as both editorial board member and peer reviewer for several international journals.